Intensive care unit management of patients with severe pulmonary hypertension and right heart failure

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 10, 2011, Pages 1114-1124

  Hoeper, Marius M ^a   Granton, John ^b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Extracorporeal life support; Intensive care; Pulmonary hypertension; Right ventricular failure

Indexed keywords

AMIODARONE; AZATHIOPRINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; DOBUTAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; ETOMIDATE; FIBRINOLYTIC AGENT; HEPARIN; ILOPROST; IMMUNOSUPPRESSIVE AGENT; KETAMINE; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; NORADRENALIN; OPIATE; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROPOFOL; PROSTACYCLIN; SEDATIVE AGENT; SILDENAFIL; UNIPROST; VASODILATOR AGENT; VASOPRESSIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANESTHESIA INDUCTION; BALLOON ATRIOSEPTOSTOMY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CARDIOVERSION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CRITICALLY ILL PATIENT; DEVICE; DIURESIS; DRUG CONTRAINDICATION; EMBOLECTOMY; END OF LIFE CARE; ENDARTERECTOMY; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL LIFE SUPPORT; EXTRACORPOREAL OXYGENATION; FIBRINOLYSIS; FLUID BALANCE; FLUID INTAKE; GENERAL ANESTHESIA; HEART AFTERLOAD; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE VOLUME; HUMAN; HYPERCAPNIA; HYPOTENSION; HYPOXEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LOW DRUG DOSE; LUNG BLOOD FLOW; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; NONINVASIVE VENTILATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; PERICARDIAL EFFUSION; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; PUMPLESS LUNG ASSIST DEVICE; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL TECHNIQUE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING; VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION; VENTILATOR;

ACUTE DISEASE; BLOOD PRESSURE; CARDIAC OUTPUT; EXTRACORPOREAL MEMBRANE OXYGENATION; FLUID THERAPY; HEART FAILURE; HUMANS; HYPERTENSION, PULMONARY; INTENSIVE CARE; LUNG TRANSPLANTATION; RESPIRATION, ARTIFICIAL;

EID: 81455150149     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201104-0662CI     Document Type: Review

References (117)

1. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349.
2. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
3. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009;34:1219-1263.
4. Faughnan M, Young L, Granton J. Pulmonary manifestations of hereditary hemorrhagic telangiectasia. Eur Respir J (In press)
5. Machado RF, Gladwin MT. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005;129:449-464. (Pubitemid 40769895)
6. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
7. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917-1928. (Pubitemid 46981654)
8. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-1619.
9. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. Circulation 2009;119:2250-2294.
10. Delcroix M, Naeije R. Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev 2010;19:204-211.
11. Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 2010;14:R169.
12. Zamanian RT, Haddad F, Doyle RL, Weinacker AB. Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 2007;35:2037-2050. (Pubitemid 47326439)
13. Via G, Braschi A. Pathophysiology of severe pulmonary hypertension in the critically ill patient. Minerva Anestesiol 2004;70:233-237. (Pubitemid 38931292)
14. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005;16:13-18. (Pubitemid 40279592)
15. Greyson CR. The right ventricle and pulmonary circulation: basic concepts. Rev Esp Cardiol 2010;63:81-95.
16. Redington AN, Rigby ML, Shinebourne EA, Oldershaw PJ. Changes in the pressure-volume relation of the right ventricle when its loading conditions are modified. Br Heart J 1990;63:45-49. (Pubitemid 20033656)
17. Sanchez-Quintana D, Climent V, Ho SY, Anderson RH. Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart 1999;81:182-191. (Pubitemid 29119396)
18. Belenkie I, Sas R, Mitchell J, Smith ER, Tyberg JV. Opening the pericardium during pulmonary artery constriction improves cardiac function. J Appl Physiol 2004;96:917-922. (Pubitemid 38248663)
19. Kroeker CA, Shrive NG, Belenkie I, Tyberg JV. Pericardium modulates left and right ventricular stroke volumes to compensate for sudden changes in atrial volume. Am J Physiol Heart Circ Physiol 2003;284:H2247-H2254. (Pubitemid 36622438)
20. Hoffman D, Sisto D, Frater RW, Nikolic SD. Left-to-right ventricular interaction with a noncontracting right ventricle. J Thorac Cardiovasc Surg 1994;107:1496-1502. (Pubitemid 24184993)
21. Santamore WP, Dell'Italia LJ. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis 1998;40:289-308. (Pubitemid 28060410)
22. Bronicki RA, Baden HP. Pathophysiology of right ventricular failure in pulmonary hypertension. Pediatr Crit Care Med 2010;11:S15-S22.
23. Matthews JC, McLaughlin V. Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 2008;4:49-59.
24. Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure - from pathophysiology to new treatments. Intensive Care Med 2004;30:185-196. (Pubitemid 38253407)
25. Tan JL, Prati D, Gatzoulis MA, Gibson D, Henein MY, Li W. The right ventricular response to high afterload: comparison between atrial switch procedure, congenitally corrected transposition of the great arteries, and idiopathic pulmonary arterial hypertension. Am Heart J 2007;153:681-688. (Pubitemid 46440699)
26. Watts JA, Marchick MR, Kline JA. Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension. J Card Fail 2010;16:250-259.
27. Brimioulle S, Wauthy P, Ewalenko P, Rondelet B, Vermeulen F, Kerbaul F, Naeije R. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003;284:H1625-H1630. (Pubitemid 36460775)
28. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009;120:992-1007.
29. Chesler NC, Roldan A, Vanderpool RR, Naeije R. How to measure pulmonary vascular and right ventricular function. Conf Proc IEEE Eng Med Biol Soc 2009;2009:177-180.
30. Fourie PR, Coetzee AR, Bolliger CT. Pulmonary artery compliance: its role in right ventricular-arterial coupling. Cardiovasc Res 1992;26:839-844.
31. Sharma S, Taegtmeyer H, Adrogue J, Razeghi P, Sen S, Ngumbela K, Essop MF. Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2004;286:H1185-H1192. (Pubitemid 38248636)
32. Simon MA. Right ventricular adaptation to pressure overload. Curr Opin Crit Care 2010;16:237-243.
33. Dias CA, Assad RS, Caneo LF, Abduch MC, Aiello VD, Dias AR, Marcial MB, Oliveira SA. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg 2002;124:999-1006. (Pubitemid 35253250)
34. Baandrup JD, Markvardsen LH, Peters CD, Schou UK, Jensen JL, Magnusson NE, Orntoft TF, Kruhoffer M, Simonsen U. Pressure load: the main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic rats. PLoS ONE 2011;6:e15859.
35. Badano LP, Ginghina C, Easaw J, Muraru D, Grillo MT, Lancellotti P, Pinamonti B, Coghlan G, Marra MP, Popescu BA, et al. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 2010;11:27-37.
36. Chen EP, Akhter SA, Bittner HB, Koch WJ, Davis RD, Van Trigt P III. Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension. Ann Thorac Surg 1999;67:1053-1058. (Pubitemid 29238295)
37. Spindler M, Schmidt M, Geier O, Sandstede J, Hahn D, Ertl G, Beer M. Functional and metabolic recovery of the right ventricle during bosentan therapy in idiopathic pulmonary arterial hypertension. J Cardiovasc Magn Reson 2005;7:853-854. (Pubitemid 41770067)
38. Faludi R, Komocsi A, Bozo J, Kumanovics G, Czirjak L, Papp L, Simor T. Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension. Eur Respir J 2008;31:475-476.
39. Gan CT, Lankhaar JW, Marcus JT, Westerhof N, Marques KM, Bronzwaer JG, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2006;290:H1528-H1533.
40. Vonk-Noordegraaf A, Marcus JT, Gan CT, Boonstra A, Postmus PE. Interventricular mechanical asynchrony due to right ventricular pressure overload in pulmonary hypertension plays an important role in impaired left ventricular filling. Chest 2005;128:628S-630S. (Pubitemid 43054174)
41. Yamaguchi S, Li KS, Harasawa H, Santamore WP. Acute alterations in systolic ventricular interdependence-mechanical dependence of right ventricle on left ventricle following acute alteration of right ventricular free wall. Basic Res Cardiol 1993;88:350-361. (Pubitemid 23301328)
42. Belenkie I, Smith ER, Tyberg JV. Ventricular interaction: from bench to bedside. Ann Med 2001;33:236-241. (Pubitemid 32500405)
43. Belenkie I, Dani R, Smith E, Tyberg J. Effects of volume loading during experimental acute pulmonary embolism. Circulation 1989;80:178-188. (Pubitemid 19178651)
44. Handoko ML, Lamberts RR, Redout EM, de Man FS, Boer C, Simonides WS, Paulus WJ, Westerhof N, Allaart CP, Vonk-Noordegraaf A. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am J Physiol Heart Circ Physiol 2009;297:H1752-H1759.
45. Gibbons Kroeker CA, Adeeb S, Shrive NG, Tyberg JV. Compression induced by RV pressure overload decreases regional coronary blood flow in anesthetized dogs. Am J Physiol Heart Circ Physiol 2006;290:H2432-H2438. (Pubitemid 43846072)
46. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120:1951-1960.
47. Humbert M, Sitbon O, Yaici A, Montani D, O'Callaghan DS, Jais X, Parent F, Savale L, Natali D, Gunther S, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36:549-555.
48. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156-163.
49. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010;122:164-172.
50. Sztrymf B, Souza R, Bertoletti L, Jais X, Sitbon O, Price LC, Simonneau G, Humbert M. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.Eur Respir J 2010;35:1286-1293.
51. Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 2005;26:2368-2374. (Pubitemid 41552965)
52. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838-1842. (Pubitemid 29251016)
53. Hoeper MM, Galie N, Murali S, Olschewski H, Rubenfire M, Robbins IM, Farber HW, McLaughlin V, Shapiro S, Pepke-Zaba J, et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165:341-344. (Pubitemid 34118506)
54. Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp JM, Niehaus M, Korte T, Hoeper MM. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007;153:127-132. (Pubitemid 44889238)
55. Goldstein JA, Harada A, Yagi Y, Barzilai B, Cox JL. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction. J Am Coll Cardiol 1990;16:181-189. (Pubitemid 20217062)
56. Adhyapak SM, Pujar SV, Mahala BK, Shetty PK. Echocardiographic evaluation of the morphology and function of the right ventricle in Eisenmenger's syndrome and idiopathic pulmonary hypertension. Indian Heart J 2006;58:341-344. (Pubitemid 44903922)
57. Ghio S, Klersy C, Magrini G, D'Armini AM, Scelsi L, Raineri C, Pasotti M, Serio A, Campana C, Vigano M. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010;140:272-278.
58. Vonk MC, Sander MH, van den Hoogen FH, van Riel PL, Verheugt FW, van Dijk AP. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007;8:317-321. (Pubitemid 47338268)
59. Lopez-Candales A, Bazaz R, Edelman K, Gulyasy B. Apical systolic eccentricity index: a better marker of right ventricular compromise in pulmonary hypertension. Echocardiography 2010;27:534-538.
60. Boissiere J, Gautier M, Machet MC, Hanton G, Bonnet P, Eder V. Doppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunction. Am J Physiol Heart Circ Physiol 2005;289:H2450-H2455. (Pubitemid 41698556)
61. Menzel T, Kramm T, Bruckner A, Mohr-Kahaly S, Mayer E, Meyer J. Quantitative assessment of right ventricular volumes in severe chronic thromboembolic pulmonary hypertension using transthoracic three-dimensional echocardiography: changes due to pulmonary thromboendarterectomy. Eur J Echocardiogr 2002;3:67-72. (Pubitemid 34732729)
62. Rajagopalan N, Simon MA, Shah H, Mathier MA, Lopez-Candales A. Utility of right ventricular tissue Doppler imaging: correlation with right heart catheterization. Echocardiography 2008;25:706-711.
63. Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005;366:472-477. (Pubitemid 41111695)
64. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003;348:5-14. (Pubitemid 36026341)
65. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 1999;27:540-544. (Pubitemid 29162674)
66. Buckley MS, Feldman JP. Nebulized milrinone use in a pulmonary hypertensive crisis. Pharmacotherapy 2007;27:1763-1766. (Pubitemid 350234321)
67. Sablotzki A, Starzmann W, Scheubel R, Grond S, Czeslick EG. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Can J Anaesth 2005;52:1076-1082.
68. Angle MR, Molloy DW, Penner B, Jones D, Prewitt RM. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism. Chest 1989;95:1333-1337. (Pubitemid 19160168)
69. Kerbaul F, Rondelet B, Motte S, Fesler P, Hubloue I, Ewalenko P, Naeije R, Brimioulle S. Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2004;32:1035-1040. (Pubitemid 38471527)
70. Braun EB, Palin CA, Hogue CW. Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. Anesth Analg 2004;99:36-37. (Pubitemid 38808159)
71. Price LC, Forrest P, Sodhi V, Adamson DL, Nelson-Piercy C, Lucey M, Howard LS. Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007;99:552-555. (Pubitemid 47412500)
72. Tayama E, Ueda T, Shojima T, Akasu K, Oda T, Fukunaga S, Akashi H, Aoyagi S. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg 2007;6:715-719. (Pubitemid 350291683)
73. Kerbaul F, Rondelet B, Demester JP, Fesler P, Huez S, Naeije R, Brimioulle S. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006;34:2814-2819. (Pubitemid 44610948)
74. Kleber FX, Bollmann T, Borst MM, Costard-Jackle A, Ewert R, Kivikko M, Petterson T, Pohjanjousi P, Sonntag S, Wikstrom G. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study. J Clin Pharmacol 2009;49:109-115.
75. Kerbaul F, Gariboldi V, Giorgi R, Mekkaoui C, Guieu R, Fesler P, Gouin F, Brimioulle S, Collart F. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure. Crit Care Med 2007;35:1948-1954. (Pubitemid 47220371)
76. Missant C, Rex S, Segers P, Wouters PF. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit Care Med 2007;35:707-715. (Pubitemid 46407782)
77. Morelli A, Teboul JL, Maggiore SM, Vieillard-Baron A, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Carbone I, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006;34:2287-2293. (Pubitemid 44260011)
78. Yontar OC, Yalta K, Yilmaz MB. Superiority of levosimendan over dobutamine in right ventricle failure. Crit Care Med 2010;38:342-343, author reply 343-344.
79. Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 2011;37:1386-1391.
80. Myles PS, Hall JL, Berry CB, Esmore DS. Primary pulmonary hypertension: prolonged cardiac arrest and successful resuscitation following induction of anesthesia for heart-lung transplantation. J Cardiothorac Vasc Anesth 1994;8:678-681.
81. Gordon C, Collard CD, Pan W. Intraoperative management of pulmonary hypertension and associated right heart failure. Curr Opin Anaesthesiol 2010;23:49-56.
82. Pritts CD, Pearl RG. Anaesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol 2010;23:6.
83. Viitanen A, Salmenpera M, Heinonen J. Right ventricular response to hypercarbia after cardiac surgery. Anesthesiology 1990;73:393-400. (Pubitemid 20298141)
84. Viitanen A, Salmenpera M, Heinonen J, Hynynen M. Pulmonary vascular resistance before and after cardiopulmonary bypass: the effect of PaCO2. Chest 1989;95:773-778. (Pubitemid 19102882)
85. Aqel RA, Aljaroudi W, Hage FG, Tallaj J, Rayburn B, Nanda NC. Left ventricular collapse secondary to pericardial effusion treated with pericardicentesis and percutaneous pericardiotomy in severe pulmonary hypertension. Echocardiography 2008;25:658-661. (Pubitemid 351861995)
86. Dunne JV, Chou JP, Viswanathan M, Wilcox P, Huang SH. Cardiac tamponade and large pericardial effusions in systemic sclerosis: a report of four cases and a review of the literature. Clin Rheumatol 2011;30:433-438.
87. Hemnes AR, Gaine SP, Wiener CM. Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension. South Med J 2008;101:490-494. (Pubitemid 351643392)
88. Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995;91:2028-2035.
89. Sandoval J, Gaspar J, Pena H, Santos LE, Cordova J, Del Valle K, Rodriguez A, Pulido T. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J (In press)
90. D'Armini AM, Zanotti G, Ghio S, Magrini G, Pozzi M, Scelsi L, Meloni G, Klersy C, Vigano M. Reverse right ventricular remodeling after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2007;133:162-168. (Pubitemid 46014213)
91. Kramer MR, Valantine HA, Marshall SE, Starnes VA, Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol 1994;73:494-500. (Pubitemid 24096213)
92. Reesink HJ, Marcus JT, Tulevski II, Jamieson S, Kloek JJ, Vonk Noordegraaf A, Bresser P. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 2007;133:58-64. (Pubitemid 46014247)
93. Rensing BJ, McDougall JC, Breen JF, Vigneswaran WT, McGregor CG, Rumberger JA. Right and left ventricular remodeling after orthotopic single lung transplantation for end-stage emphysema. J Heart Lung Transplant 1997;16:926-933. (Pubitemid 27408737)
94. Olschewski H, Ghofrani HA, Schmehl T, Winkler J, Wilkens H, Hoper MM, Behr J, Kleber FX, Seeger W; German PPH Study Group. Inhaled iloprost to treat severe pulmonary hypertension: an uncontrolled trial. Ann Intern Med 2000;132:435-443. (Pubitemid 30149040)
95. Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W; German PPH Study Group. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. J Am Coll Cardiol 2000;35:176-182. (Pubitemid 30061277)
96. Bhorade S, Christenson J, O'Connor M, Lavoie A, Pohlman A, Hall JB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999;159:571-579. (Pubitemid 29084883)
97. Della Rocca G, Coccia C, Pompei L, Costa MG, DiMarco P, Pietropaoli P. Inhaled aerosolized prostaglandin E1, pulmonary hemodynamics, and oxygenation during lung transplantation. Minerva Anestesiol 2008;74:627-633.
98. Della Rocca G, Coccia C. Nitric oxide in thoracic surgery. Minerva Anestesiol 2005;71:313-318. (Pubitemid 40932278)
99. George I, Xydas S, Topkara VK, Ferdinando C, Barnwell EC, Gableman L, Sladen RN, Naka Y, Oz MC. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg 2006;82:2161-2169.
100. Vachiery JL, Huez S, Gillies H, Layton G, Hayashi N, Gao X, Naeije R. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol 2011;71:289-292.
101. Jais X, Launay D, Yaici A, Le Pavec J, Tcherakian C, Sitbon O, Simonneau G, Humbert M. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008;58:521-531. (Pubitemid 351294886)
102. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007;116:1555-1562. (Pubitemid 47511419)
103. Mehta S, Helmersen D, Provencher S, Hirani N, Rubens FD, De Perrot M, Blostein M, Boutet K, Chandy G, Dennie C, et al. Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J 2010;17:301-334.
104. Montani D, O'Callaghan DS, Savale L, Jais X, Yaici A, Maitre S, Dorfmuller P, Sitbon O, Simonneau G, Humbert M. Pulmonary veno-occlusive disease: recent progress and current challenges. Respir Med 2010;104:S23-S32.
105. Palazzini M, Manes A. Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension. Eur Respir Rev 2009;18:177-180.
106. Detsky ME, Balter MS, Sridhar SK, Granton J. Clinical problem-solving: under pressure. N Engl J Med 2010;362:449-454.
107. Montani D, Jais X, Dorfmuller P, Simonneau G, Sitbon O, Humbert M. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. Eur Respir J 2009;34:1204-1206.
108. Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twentyseventh official adult lung and heart-lung transplant report - 2010. J Heart Lung Transplant 2010;29:1104-1118.
109. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Kotloff R, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the pulmonary scientific council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-755. (Pubitemid 43963375)
110. Fischer S, Hoeper MM, Tomaszek S, Simon A, Gottlieb J, Welte T, Haverich A, Strueber M. Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the venovenous mode: the initial Hannover experience. ASAIO J 2007;53:168-170. (Pubitemid 46597565)
111. Fischer S, Simon AR, Welte T, Hoeper MM, Meyer A, Tessmann R, Gohrbandt B, Gottlieb J, Haverich A, Strueber M. Bridge to lung transplantation with the novel pumpless interventional lung assist device Novalung. J Thorac Cardiovasc Surg 2006;131:719-723.
112. Olsson KM, Simon A, Strueber M, Hadem J, Wiesner O, Gottlieb J, Fuehner T, Fischer S, Warnecke G, Kuhn C, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010;10:2173-2178.
113. Strueber M, Hoeper MM, Fischer S, Cypel M, Warnecke G, Gottlieb J, Pierre A, Welte T, Haverich A, Simon AR, et al. Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant 2009;9:853-857.
114. Schmid C, Philipp A, Hilker M, Arlt M, Trabold B, Pfeiffer M, Schmid FX. Bridge to lung transplantation through a pulmonary artery to left atrial oxygenator circuit. Ann Thorac Surg 2008;85:1202-1205. (Pubitemid 351381679)
115. Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, Butz B, Birnbaum D, Taeger K, Schlitt HJ. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 2006;34:1372-1377.
116. Satoh H, Masuda Y, Izuta S, Yaku H, Obara H. Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy. Anesthesiology 2002;97:1638-1640. (Pubitemid 35417470)
117. Erzurum S, Rounds SI, Stevens T, Aldred M, Aliotta J, Archer SL, Asosingh K, Balaban R, Bauer N, Bhattacharya J, et al. Strategic plan for lung vascular research: an NHLBI-ORDR workshop report. Am J Respir Crit Care Med 2010;182:1554-1562.